Sunshine Biopharma Inc.

Sunshine Biopharma announced a one‑for‑10 reverse stock split effective June 1 2026 to meet Nasdaq’s minimum bid price rule. The split will cut issued shares from 21,236,346 to about 2,123,635, reduci